Clinical Trial Update: Tolerability and Activity of Brivaracetam (BRV) in Patients With Diffuse Gliomas [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update describes the tolerability and preliminary activity of brivaracetam in patients with diffuse gliomas in an early-phase study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Gliomas

Drugs mentioned

• BRIVARACETAM (brivaracetam)

Snippet

Sponsor: University of Rochester | Conditions: Brain Tumor | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING